Clinical trial NCT02073903: The Use of Dual-handset Interpreter Phones in an Inpatient Setting to Improve Communication With Limited English Proficiency Patients at MSKCC
Official title: The Use of Dual-handset Interpreter Phones in an Inpatient Setting to Improve Communication With Limited English Proficiency Patients at MSKCC
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Inpatients With Limited English Proficiency
Keywords: dual handset interpreter phones
communication
14-042
Lead sponsor: Memorial Sloan Kettering Cancer Center
Sponsor class: OTHER
First posted: 2014-02-27
Enrollment: 40
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Patient Support Services will generate a daily list of inpatients that prefer to communicate in a language other than English.

Brief summary: The purpose of this study is to introduce new technology and interpreter practices in the inpatient setting at MSKCC. We plan to install dual handset phones at the bedsides of limited English proficiency (LEP) patients and to assess the impact on both patient and physician communication effectiveness with this technology.

Detailed description: During the first 5-6 weeks of the study standard of care will be conducted as usual practice by the medicine teams at MSKCC. It is expected that during that time they will care for at least 20 LEP patients who meet our inclusion criteria. There are no specific target numbers for any of the included languages. During the following 5-6 weeks, the phones will be installed by the 10 house-staff teams and approximately an additional 20 LEP patients who meet the protocol inclusion criteria will be enrolled. Therefore, in the first half of this study about 20 LEP patients and 40 practitioners (two practitioners per LEP patient) will provide data and the same numbers will account for the second half of the study after the intervention is instituted. There will be no randomization of patients or physicians. The only data that will be analyzed are those questions from the surveys to assess communication effectiveness with LEP patients. The number of patients who are interviewed will depend on MSKCC inpatient census at the time of study.

Eligibility criteria: Inclusion Criteria:

* LEP patients identified by the Department of Interpreter Services at MSKCC admitted to the Hepatobiliary surgery service, the Colorectal Surgery service the GMT surgery service, GI, GU, Breast, General Medicine, Leukemia, or Lymphoma services with a primary language of Spanish, Russian, or Chinese.
* LEP patients who are expected to have at least a two days hospital course.
* Patients who are alert and oriented to person, place, and time as determined by the medical doctor taking care of the patient
* Patients who are willing to participate and complete the survey
* Patients whose physicians and nurses are willing to participate
* Only persons ≥ 18 will be included and there will be no children.
* Providers must be willing to participate and complete the survey
* TY interns cannot complete provider surveys

Exclusion Criteria:

* Patients on contact isolation
* Patients who previously completed the survey

Primary outcomes:
measure: Patient communication effectiveness
timeFrame: 1 year
Secondary outcomes:
measure: Physician and nurse communication effectiveness
timeFrame: 1 year
Other outcomes:
Locations:
city: New York
country: United States
facility: Memorial Sloan Kettering Cancer Center
state: New York
Study officials:
affiliation: Memorial Sloan Kettering Cancer Center
name: Chhavi Kumar, MD
role: PRINCIPAL_INVESTIGATOR
References: